K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 257 JPY 0.47% Market Closed
Market Cap: 161.2B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Kaken Pharmaceutical Co Ltd

Wall Street analysts forecast Kaken Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 947 JPY with a low forecast of 3 636 JPY and a high forecast of 6 405 JPY.

Lowest
Price Target
3 636 JPY
15% Downside
Average
Price Target
4 947 JPY
16% Upside
Highest
Price Target
6 405 JPY
50% Upside
Kaken Pharmaceutical Co Ltd Competitors:
Price Targets
AQST
Aquestive Therapeutics Inc
208% Upside
VY4
SNDL Inc
84% Upside
PFE
Pfizer Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Kaken Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's revenue is -5%. The projected CAGR for the next 3 years is -5%.

-5%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Kaken Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Kaken Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Kaken Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's net income is -11%. The projected CAGR for the next 3 years is -62%.

-11%
Past Growth
-62%
Estimated Growth
Estimates Accuracy
6%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kaken Pharmaceutical Co Ltd's stock price target?
Price Target
4 947 JPY

According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 947 JPY with a low forecast of 3 636 JPY and a high forecast of 6 405 JPY.

What is Kaken Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's revenue is -5%. The projected CAGR for the next 3 years is -5%.

What is Kaken Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-62%

For the last 8 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's net income is -11%. The projected CAGR for the next 3 years is -62%.

Back to Top